As of 2025-07-15, the Relative Valuation of BioXcel Therapeutics Inc (BTAI) is (144.45) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.02 USD, the upside of BioXcel Therapeutics Inc based on Relative Valuation is -7250.9%.
The range of the Relative Valuation is (93.87) - (177.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 26.9x | 20.3x |
| Forward P/E multiples | 14.2x - 32.6x | 23.4x |
| Fair Price | (93.87) - (177.83) | (144.45) |
| Upside | -4747.3% - -8903.6% | -7250.9% |
| Date | P/E |
| 2025-07-11 | -0.30 |
| 2025-07-10 | -0.30 |
| 2025-07-09 | -0.30 |
| 2025-07-08 | -0.30 |
| 2025-07-07 | -0.29 |
| 2025-07-03 | -0.29 |
| 2025-07-02 | -0.29 |
| 2025-07-01 | -0.30 |
| 2025-06-30 | -0.27 |
| 2025-06-27 | -0.27 |
| 2025-06-26 | -0.31 |
| 2025-06-25 | -0.31 |
| 2025-06-24 | -0.26 |
| 2025-06-23 | -0.25 |
| 2025-06-20 | -0.24 |
| 2025-06-18 | -0.26 |
| 2025-06-17 | -0.25 |
| 2025-06-16 | -0.26 |
| 2025-06-13 | -0.24 |
| 2025-06-12 | -0.27 |
| 2025-06-11 | -0.27 |
| 2025-06-10 | -0.30 |
| 2025-06-09 | -0.30 |
| 2025-06-06 | -0.28 |
| 2025-06-05 | -0.23 |
| 2025-06-04 | -0.23 |
| 2025-06-03 | -0.21 |
| 2025-06-02 | -0.20 |
| 2025-05-30 | -0.18 |
| 2025-05-29 | -0.19 |
| 2025-05-28 | -0.19 |
| 2025-05-27 | -0.21 |
| 2025-05-23 | -0.21 |
| 2025-05-22 | -0.21 |
| 2025-05-21 | -0.21 |
| 2025-05-20 | -0.21 |
| 2025-05-19 | -0.22 |
| 2025-05-16 | -0.22 |
| 2025-05-15 | -0.22 |
| 2025-05-14 | -0.21 |
| 2025-05-13 | -0.22 |
| 2025-05-12 | -0.22 |
| 2025-05-09 | -0.23 |
| 2025-05-08 | -0.24 |
| 2025-05-07 | -0.23 |
| 2025-05-06 | -0.24 |
| 2025-05-05 | -0.26 |
| 2025-05-02 | -0.27 |
| 2025-05-01 | -0.27 |
| 2025-04-30 | -0.28 |